Compare Bitdeer Technologies Group (BTDR) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bitdeer Technologies Group vs Neurocrine Biosciences Inc — how do they compare? Bitdeer Technologies Group trades at $8.97 (market cap $2.36B), while Neurocrine Biosciences Inc trades at $156 (market cap $16.46B). The key difference: Neurocrine Biosciences Inc is far larger — about 7× Bitdeer Technologies Group's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Bitdeer Technologies Group nearer its low. Which is the better fit depends on your goals.
| BTDR | NBIX | |
|---|---|---|
Market Cap | $2.36B | $16.46B |
Sector | Technology | Health |
52-Week High | $25.90 | $185.50 |
52-Week Low | $7.28 | $123.10 |
Enterprise Value | $3.85B | $16.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bitdeer Technologies Group
Bitdeer is a world-leading technology company for blockchain and high-performance computing. It provides comprehensive digital asset mining solutions, including cloud mining, hosting, and data center management.
Read more on BTDR →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
